4//SEC Filing
Kinard David S 4
Accession 0001415889-22-002471
CIK 0001739104other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:01 PM ET
Size
10.4 KB
Accession
0001415889-22-002471
Insider Transaction Report
Form 4
Kinard David S
SEE REMARKS
Transactions
- Award
Common Stock
2022-03-01+8,665→ 97,241 total - Tax Payment
Common Stock
2022-03-01$28.94/sh−1,724$49,893→ 95,517 total - Tax Payment
Common Stock
2022-03-02$29.00/sh−874$25,346→ 94,643 total - Award
Employee Stock Option(right to buy)
2022-03-01+23,026→ 23,026 totalExercise: $28.94Exp: 2032-03-01→ Common Stock (23,026 underlying)
Footnotes (3)
- [F1]Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.
- [F2]Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan
- [F3]Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.
Documents
Issuer
Elanco Animal Health Inc
CIK 0001739104
Entity typeother
Related Parties
1- filerCIK 0001752439
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:01 PM ET
- Size
- 10.4 KB